Login to Your Account

Financings Roundup

Back in 'Control': Tivo Data Explained; AVEO Bags $50M

By Randy Osborne
Staff Writer

Friday, January 18, 2013

Stock buyers are putting their faith in AVEO Oncology Inc. to the tune of about $50 million in gross proceeds, coming the firm's way through a public offering expected to close later this month.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription